CoChat

Neuropathological validation of the MDS-PSP criteria with PSP and other frontotemporal lobar degeneration

Open access
Gazzina, Stefano, Respondek, Gesine, Compta, Yaroslau, Allinson, Kieren S.J., Spillantini, Maria G., Molina-Porcel, Laura, Guasp-Verdaguer, Mar, Moftakhar, Shirin, Reich, Stephen G., Hall, Deborah, Litvan, Irene, Höglinger, Günter U., Movement Disorder Society-endorsed PSP Study Group, Rowe, James B. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
PreprintCited by 24

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: Progressive supranuclear palsy (PSP) is clinically heterogeneous. Clinical diagnostic criteria were revised in 2017, to increase sensitivity and operationalize the diagnosis of PSP Richardson’s syndrome (PSP-RS) and “variant” syndromes (vPSP). Objectives: To determine the (1) sensitivity and specificity of the 1996 NINDS-SPSP and 2017 MDS-PSP criteria; (2) false positive rates in frontotemporal dementia with frontotemporal lobar degeneration (FTLD); and (3) clinical evolution of variant PSP syndromes (vPSP). Methods: Retrospective multicenter review of 108 neuropathologically-confirmed PSP patients and 81 patients with other forms of FTLD: 38 behavioral variant frontotemporal dementia (bvFTD), 14 non-fluent/agrammatic variant primary progressive aphasia (nfvPPA), and 29 corticobasal degeneration (CBD), Sensitivity and specificity of the MDS-PSP criteria were compared to the NINDS-SPSP criteria at baseline. In a subset of cases, the timing and frequency of clinical features were compared across groups over six years. Results: Sensitivity for recognition of probable and possible PSP pathology was higher by MDS-PSP criteria (72.2-100%) than NINDS-SPSP criteria (48.1-61.1%). Specificity was higher by NINDS-SPSP criteria (97.5-100%) than MDS-PSP criteria (53.1-95.1%). False positives by MDS-PSP criteria were few for bvFTD (10.5-18.4%) but common for CBD and nfvPPA (fulfilling “suggestive of’ PSP). Most vPSP cases developed PSP-RS-like features within six years, including falls and supranuclear gaze palsy, distinguishing frontal presentations of PSP from bvFTD, and speech/language presentations of PSP from nfvPPA. Conclusions: The 2017 MDS-PSP criteria successfully identify PSP, including variant phenotypes. This independent validation of the revised clinical diagnostic criteria strengthens the case for novel therapeutic strategies against PSP to include variant presentations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/520510

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 24

Metadata

Authors
Gazzina, S., Respondek, G., Compta, Y., Allinson, K. S. J., Spillantini, M. G., Molina-Porcel, L., Guasp-Verdaguer, M., Moftakhar, S., Reich, S. G., Hall, D., Litvan, I., Höglinger, G. U., Movement Disorder Society-endorsed PSP Study Group, & Rowe, J. B.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2019-01-15
OpenAlex
W2910203560
Cited by
24
References
6
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuropathological validation of the MDS-PSP criteria with PSP and other frontotemporal lobar degeneration. https://app.cochat.ai/papers/10.1101/520510
The paper
Gazzina, S., Respondek, G., Compta, Y., Allinson, K. S. J., Spillantini, M. G., Molina-Porcel, L., Guasp-Verdaguer, M., Moftakhar, S., Reich, S. G., Hall, D., Litvan, I., Höglinger, G. U., Movement Disorder Society-endorsed PSP Study Group, & Rowe, J. B. (2019). Neuropathological validation of the MDS-PSP criteria with PSP and other frontotemporal lobar degeneration. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/520510

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.